Heterozygous mutations in COPA are associated with enhanced type I interferon signalling

Archive ouverte

Frémond, Marie-Louise | Lepelley, Alice | Uggenti, Carolina | Martin-Niclos, Maria José | Depp, Marine | Bondet, Vincent | Duffy, Darragh | Rice, Gillian | Brennan, Mary | Thumerelle, Caroline | Boulisfane-El Khalifi, Siham | Legendre, Marie | Amselem, Serge | Jo Molina, Thierry | Nathan, Nadia | Crow, Yanick, J.

Edité par CCSD -

International audience. Introduction: Heterozygous mutations in COPA, encoding coatomer protein subunit alpha, cause an autosomal dominant inflammatory syndrome associating lung, joint and renal disease, showing some overlap with STING-associated vasculopathy with onset in infancy (SAVI). Mutations were originally described to cause endoplasmic reticulum (ER) stress and priming of a T helper 17 response. More recently, increased transcription of interferon (IFN)-stimulated genes (ISGs) was reported in blood circulating cells of affected individuals. However, the precise pathophysiology of this disease remains unclear.Objectives: To better decipher the mechanism of COPA syndrome.Methods: We studied 8 patients from 3 unrelated families, each segregating a heterozygous mutation in COPA. We assessed type I IFN status by IFNa ultra-sensitive digital quantification in plasma, STAT1 phosphorylation and RNA expression of ISGs in whole blood from patients. In vitro assays also were performed in HEK293T and THP-1 cells to study IFN signalling in the context of COPA mutations.Results: We observed commonalities in the lung pathology between COPA and SAVI, as well as an IFN signature, raised levels of IFNa protein in the serum and phosphorylation of STAT1 in patient T cells. In a cellular model of HEK293T, phosphorylation of IRF3 and increased ISG expression were observed in cells co-transfected with wild type STING and mutant COPA plasmids. In THP-1 cells, short hairpin RNA knockdown of COPA induced IFN signalling that was abrogated in the absence of STING.Conclusion: Our data suggest that mutations in COPA lead to constitutive activation of type I IFN signalling through STING. Based on these results, one patient has been treated with the JAK1/2 inhibitor ruxolitinib for the last 12 months. How COPA interacts with ER-resident STING remains to be investigated.

Consulter en ligne

Suggestions

Du même auteur

OP0107 HETEROZYGOUS MUTATIONS IN COPA ARE ASSOCIATED WITH ENHANCED TYPE I INTERFERON SIGNALLING

Archive ouverte | Frémond, Marie-Louise | CCSD

International audience

Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling

Archive ouverte | Lepelley, Alice | CCSD

International audience. Heterozygous missense mutations in coatomer protein subunit α, COPA, cause a syndrome overlapping clinically with type I IFN-mediated disease due to gain-of-function in STING, a key adaptor o...

Le recyclage de STING par COPA freine l’inflammation

Archive ouverte | Lepelley, Alice | CCSD

International audience

Chargement des enrichissements...